Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

34 filings reported holding MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.48M shares of 16.9M outstanding shares and own 20.61% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (1.63M shares), Blue Owl Capital Holdings LP (554K shares), Hudson Bay Capital Management LP (332K shares), Aisling Capital Management LP (325K shares), VANGUARD GROUP INC (243K shares), LPL Financial LLC (79.7K shares), GEODE CAPITAL MANAGEMENT, LLC (75.7K shares), NORTHERN TRUST CORP (54.2K shares), RENAISSANCE TECHNOLOGIES LLC (40.1K shares), and STATE STREET CORP (20.9K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.